BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2003
View Archived Issues
Testim reported safe and effective for treating male hypogonadism
Read More
Good efficacy and safety profile found for solifenacin in patients with overactive bladder
Read More
Clomiphene citrate increases endogenous testosterone levels in PHAM
Read More
Antitumor efficacy reported for radiolabeled J591 in advanced prostate cancer
Read More
Key product and corporate highlights at Human Genome Sciences
Read More
Synaptic presents neuropeptide FF receptor modulators for use in pain and urinary incontinence
Read More
Novel calcium channel blockers and their use in hypertension, angina, etc.
Read More
New tyrosine kinase inhibitors covered by Allergan patent
Read More
Kyowa Hakko scientists prepare and test new steroid sulfamate inhibitors
Read More
Dual CCR3 modulators/H1 antagonists identified by AstraZeneca researchers
Read More
Novel MMP inhibitors in early development at Pfizer
Read More
20-HETE production inhibitors and their use reported by Taisho
Read More
Bayer researchers discover serine-based alphav integrin antagonists
Read More
GSK claims Trk kinase inhibitors with utility in the treatment of cancer and pain
Read More
Antitumor Tie-2/VEGFR2 inhibitors newly discovered at GSK
Read More
Prous Science announces publication of state-of-the-art review: macular degeneration
Read More
Celltech offer for Oxford GlycoSciences declared unconditional
Read More
Fujisawa replaces FK-960 for Alzheimer's disease with analogue
Read More
Low-dose Premarin receives FDA approval
Read More
Vicuron submits anidulafungin NDA for esophageal candidiasis
Read More
Final topline 48-week data for Fuzeon
Read More
Noven receives nonapprovable letter for methylphenidate transdermal system
Read More
Trospium NDA submitted for overactive bladder
Read More
Oxytrol available for overactive bladder
Read More
Potentially more effective BCG-based therapy for bladder cancer discussed at AUA meeting
Read More
Ad5-PSA gene therapy well tolerated in patients with prostate cancer
Read More
